Omar Al-Massadi | Metabolism | Best Researcher Award

Published on by Global Scholar Awards

Dr. Omar Al-Massadi | Metabolism | Best Researcher Award

PhD at IDIS, Spain

Dr. Omar Al-Massadi Iglesias is a distinguished biomedical researcher specializing in neuroendocrinology, obesity, and metabolic diseases. With over two decades of experience in academic research, he has made pivotal contributions to the understanding of energy homeostasis, hypothalamic signaling, and obesity-linked complications like type 2 diabetes. Currently serving as a Principal Investigator under the Miguel Servet program at the Instituto de Investigación Sanitaria de Santiago de Compostela, he leads the “Endocrinología Traslacional” group. His career spans multiple high-impact international collaborations and includes over 66 peer-reviewed publications, many in Q1 journals like Nature Communications, Cell Metabolism, and Diabetes. He is also a reviewer for more than 90 scientific journals and has contributed to both academic and clinical translational research. Dr. Al-Massadi’s work has not only advanced science but also impacted public health policies and treatment strategies, making him a highly influential figure in his field.

Professional Profile 

Google Scholar | Scopus Profile | ORCID Profile 

Education

Dr. Al-Massadi earned a degree in Molecular Biology and Biotechnology from the University of Santiago de Compostela in 2000. He pursued his doctoral studies at the same institution, obtaining a Ph.D. in Physiology in 2010. His doctoral work, which earned him the Extraordinary Doctorate Prize, provided a strong foundation in neuroendocrinology and metabolic regulation. Following this, he enhanced his academic profile through advanced postdoctoral training at top international institutions. Notably, he completed a postdoctoral fellowship at the University of Cincinnati (USA) under the mentorship of Prof. Matthias Tschöp, a globally recognized leader in obesity and diabetes research. He later undertook another postdoctoral position at INSERM-Sorbonne Université in Paris, deepening his expertise in cellular signaling and metabolism. This comprehensive academic journey, combining rigorous theoretical training with international research exposure, has positioned Dr. Al-Massadi as a well-rounded and globally competent scientist.

Experience

Dr. Al-Massadi’s professional experience spans over 20 years in academic and translational research. His career began as a Ph.D. student and early postdoctoral researcher at the University of Santiago de Compostela and the Complejo Hospitalario Universitario de Santiago. He later gained significant international experience in the USA and France, including his pivotal work at the University of Cincinnati and INSERM-Sorbonne Université. Throughout his career, he has participated in 21 competitive research projects, including several as Principal Investigator, and contributed to numerous clinical and preclinical studies. His current role as Principal Investigator in the Miguel Servet program has allowed him to establish his own research group, mentoring graduate students and securing national and regional funding. He has authored over 66 scientific articles, served as a peer reviewer for major journals, and actively contributed to international research networks. His broad experience encompasses molecular biology, endocrinology, neuroscience, and translational medicine.

Research Interest

Dr. Al-Massadi’s primary research interests lie in neuroendocrinology, obesity, and metabolic disease mechanisms. He is particularly focused on understanding the molecular signaling pathways in the hypothalamus that regulate energy homeostasis, appetite, and glucose metabolism. His recent investigations explore the role of Pyk2, a tyrosine kinase, in obesity-induced complications such as type 2 diabetes, aiming to uncover novel therapeutic targets. His translational approach bridges fundamental science with clinical application, particularly in developing innovative treatments for metabolic disorders. He is also interested in mitochondrial dynamics, hormone signaling (e.g., ghrelin and glucagon), and sex-specific metabolic regulation. Through animal models, molecular tools, and human data, Dr. Al-Massadi has made critical contributions to identifying biomarkers and intervention strategies. His passion for interdisciplinary research and commitment to solving real-world health problems make his work both scientifically robust and socially impactful.

Awards and Honors

Dr. Al-Massadi has received numerous accolades recognizing his excellence in scientific research. He was awarded the Extraordinary Doctorate Prize by the University of Santiago de Compostela for his outstanding Ph.D. work. His research contributions have earned him Best Poster and Best Oral Communication awards at national endocrinology and obesity congresses. In 2019, the Spanish Society of Endocrinology and Nutrition honored his work as the Best Published Article of the year. His research has attracted competitive funding through prestigious contracts, including the Miguel Servet, Sara Borrell, and Xunta de Galicia Talent Attraction programs. He has also received international mobility grants and been invited to deliver keynote lectures and scientific talks. In addition, Dr. Al-Massadi holds a European patent (EP24382850.6) for a diagnostic and prognostic method related to obesity. These recognitions highlight not only his scientific talent but also his dedication to translational and impactful biomedical research.

Research Skills

Dr. Al-Massadi possesses an extensive skill set across multiple domains of biomedical research. His core competencies include molecular and cellular biology, animal models of metabolic disease, neuroendocrine regulation, and mitochondrial physiology. He is highly proficient in designing and managing complex experiments involving gene expression analysis, CRISPR/Cas9, immunohistochemistry, and biochemical assays. He has demonstrated expertise in project leadership, securing and managing competitive funding, and supervising doctoral and master’s-level research. His collaborative skills are evidenced by partnerships with global institutions and his active role in multidisciplinary teams. Additionally, he excels in scientific writing, having authored high-impact publications, reviews, and book chapters. As a peer reviewer and scientific committee member, he has evaluated grant proposals and journal articles, showcasing his analytical acumen. His patent development experience reflects innovation, while his communication and mentoring abilities add to his profile as a holistic and forward-thinking researcher.

Publications Top Notes

Title: Central Obestatin and Food Intake Regulation
Authors: CFF Seoane LM, Al-Massadi O, Pazos Y, Pagotto U
Year: 2006
Citation Count: 158

Title: Exercise and Hypothalamic Inflammation
Authors: CX Yi, O Al-Massadi, E Donelan, M Lehti, J Weber, C Ress, C Trivedi, …
Year: 2012
Citation Count: 149

Title: Hypothalamic Ghrelin Pathways and Appetite
Authors: O Al Massadi, M López, M Tschöp, C Diéguez, R Nogueiras
Year: 2017
Citation Count: 148

Title: HDL and Skeletal Muscle Function
Authors: M Lehti, E Donelan, W Abplanalp, O Al-Massadi, KM Habegger, J Weber, …
Year: 2013
Citation Count: 112

Title: MCH and Metabolism Regulation
Authors: M Imbernon, D Beiroa, MJ Vázquez, DA Morgan, C Veyrat–Durebex, …
Year: 2013
Citation Count: 111

Title: Obestatin in Adipocyte Metabolism
Authors: U Gurriarán‐Rodríguez, O Al‐Massadi, A Roca‐Rivada, AB Crujeiras, …
Year: 2011
Citation Count: 103

Title: Ghrelin Acylation and Metabolic Control
Authors: O Al Massadi, MH Tschöp, J Tong
Year: 2011
Citation Count: 96

Title: Ghrelin and Food Reward
Authors: O Al Massadi, R Nogueiras, C Dieguez, JA Girault
Year: 2019
Citation Count: 95

Title: Gastric CB1 Receptor and Ghrelin via mTOR
Authors: LL Senin, O Al-Massadi, C Folgueira, C Castelao, M Pardo, …
Year: 2013
Citation Count: 82

Conclusion

Dr. Omar Al-Massadi Iglesias is an exceptional candidate for the Best Researcher Award, with a track record of excellence in research, innovation, and mentorship. His contributions to the field of obesity and endocrinology are globally recognized, and he has made significant strides in understanding metabolic disorders with clinical implications. His trajectory from international postdoctoral training to becoming an independent research leader, coupled with his prolific publication record and sustained grant success, showcase his future potential as a transformative leader in biomedical research. His work not only advances scientific knowledge but also contributes meaningfully to public health—making him truly deserving of this prestigious recognition.

Ignacio Sajoux | Obesity | Best Researcher Award

Published on by Global Scholar Awards

Dr. Ignacio Sajoux | Obesity | Best Researcher Award

Chief Scientific Officer at Pronokal Group, Spain

Dr. Luis Ignacio Sajoux Parrile is a distinguished clinical researcher and scientific leader with a strong focus on obesity, metabolic disorders, and ketogenic dietary interventions. Serving as Chief Scientific Officer and Scientific Director at Pronokal Group (a Nestlé Health Science company), he has led innovative research resulting in patented methodologies applied across 18 countries. With over a decade of experience, his work includes coordinating international clinical trials, advancing genomic-based treatments, and publishing in reputable journals such as Endocrine and Nutr Diabetes. Ranked among the most influential global authors in very low-calorie ketogenic diets (VLCKD), he holds an h-index of 13 and g-index of 19. Dr. Sajoux also founded the Neurometrics Institute, integrating neuroscience with nutrition and behavior research. His contributions extend to policy, strategic leadership, and international scientific collaboration. While further academic mentorship and recent publications could strengthen his profile, he is highly deserving of the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Luis Ignacio Sajoux Parrile holds a comprehensive and multidisciplinary educational background that bridges clinical medicine, surgery, business, and aesthetic science. He earned his medical degree from the University of Buenos Aires in 2003, followed by a General Surgery specialization completed at the French University Hospital in 2008. His academic path then expanded into healthcare management and innovation with an Executive MBA (EMBA) from ESADE Business School in 2017, one of Europe’s top institutions for business leadership. Further enhancing his clinical expertise, he completed a Master’s degree in Aesthetic Medicine at the University of Barcelona in 2022. This diverse educational foundation supports his ability to integrate medical science, clinical research, strategic management, and technological innovation. It has enabled him to lead complex research initiatives, oversee clinical trials, and develop patented methodologies in nutrition and obesity treatment across international settings. His academic trajectory reflects a strong commitment to lifelong learning and multidisciplinary excellence.

Professional Experience📝

Dr. Luis Ignacio Sajoux Parrile has built a dynamic professional career at the intersection of clinical medicine, scientific research, and corporate leadership. Beginning in Buenos Aires, he specialized in Digestive Surgery after earning his medical degree, then relocated to Barcelona to focus on obesity treatment and clinical research. Since 2010, he has served as Chief Scientific Officer at Pronokal Health Group, now part of Nestlé Health Science, where he has led numerous clinical trials and developed patented nutritional strategies implemented in over 18 countries. He also serves as Scientific Director of the Biobank Genomics and President of the Compliance Committee, guiding genomic-based obesity research and ethical oversight. In 2015, he founded the Neurometrics Institute, focusing on neurobehavioral research in obesity, ADHD, and autism. His work bridges clinical innovation, public health, and strategic corporate growth, including participation in corporate acquisitions and digital transformation, making him a recognized leader in evidence-based healthcare solutions.

Research Interest🔎

Dr. Luis Ignacio Sajoux Parrile’s research interests center on obesity management, metabolic health, ketogenic dietary therapies, and the integration of genomics and neuroscience in clinical practice. He is particularly recognized for his pioneering work on very low-calorie ketogenic diets (VLCKD), contributing to both the scientific understanding and clinical application of these interventions in treating obesity and type 2 diabetes. His research also explores the mechanisms of lipoinflammation, the impact of DHA supplementation, and the long-term effects of nutritional strategies on visceral fat reduction. Dr. Sajoux has expanded his focus to include neurocognitive development, especially in pediatric populations with conditions such as ADHD and autism, through protein-based nutritional interventions. He actively contributes to real-world clinical studies and the design of genomics-based personalized treatment plans. By combining clinical science with translational innovation, his work supports the development of multidisciplinary approaches to obesity and behavioral health, improving patient outcomes across diverse populations and healthcare systems.

Award and Honor🏆

Dr. Luis Ignacio Sajoux Parrile has earned recognition and honors for his significant contributions to clinical research, particularly in the field of obesity and ketogenic nutritional therapy. A recent bibliometric analysis published in Endocrine, Metabolic & Immune Disorders—Drug Targets ranked him among the most influential global authors in the field of very low-calorie ketogenic diets (VLCKD), underscoring his impact and leadership in this area. His patented nutritional methodologies are used across 18 countries, reflecting the international relevance and application of his innovations. As a respected figure in scientific and medical communities, he is frequently invited to speak at international congresses and symposia focused on obesity, metabolism, and nutritional science. Additionally, Dr. Sajoux has been instrumental in forming and leading expert panels, international boards, and clinical research collaborations. These roles demonstrate not only his scientific expertise but also his ability to influence healthcare practices and policies across borders through impactful, evidence-based contributions.

Research Skill🔬

Dr. Luis Ignacio Sajoux Parrile possesses a comprehensive set of research skills that span clinical trial design, epidemiological study coordination, biomedical innovation, and translational science. His expertise lies in developing and implementing real-world clinical studies, particularly in the areas of obesity, metabolic disorders, and ketogenic dietary interventions. He is skilled in leading multidisciplinary research teams, managing complex datasets, and applying systems biology approaches to understand the molecular mechanisms underlying nutritional therapies. Dr. Sajoux demonstrates strong analytical and problem-solving abilities, evident in his development of two patented nutritional methodologies currently applied in over 18 countries. His ability to bridge clinical research with genomic diagnostics enhances the personalization of treatment strategies. Additionally, his founding of the Neurometrics Institute highlights his proficiency in neurobehavioral research, particularly in populations with ADHD and autism. With experience in both corporate and academic environments, he excels in translating scientific findings into practical healthcare solutions with global impact.

Conclusion💡

Dr. Luis Ignacio Sajoux Parrile is highly suitable for the Best Researcher Award, particularly in the domain of obesity treatment, ketogenic dietary interventions, and clinical research innovation. His blend of scientific rigor, translational outcomes, and international recognition supports a compelling case for the award. While improvements in academic independence and broader research dissemination could further elevate his candidacy, his leadership and contributions already place him as a strong contender.

Publications Top Noted✍️

  • Obesity-related osteopontin protein and methylation blood levels are differentially modulated by a very low-calorie ketogenic diet or bariatric surgery
    Authors: Lorenzo, P.M.; Izquierdo, A.G.; Sajoux, I.; Nuñez-Garcia, M.; Gomez-Arbelaez, D.; Zulet, M.A.; Abete, I.; Baltar, J.; de Luis, D.; Tinahones, F.J.
    Year: 2025
    Citation: Clinical Nutrition (Edinburgh, Scotland), DOI: 10.1016/j.clnu.2025.02.006

  • A very-low-calorie ketogenic diet normalises obesity-related enhanced levels of erythropoietin compared with a low-calorie diet or bariatric surgery
    Authors: Fernandez-Pombo, A.; Lorenzo, P.M.; Carreira, M.C.; Gomez-Arbelaez, D.; Castro, A.I.; Primo, D.; Rodriguez, J.; Sajoux, I.; Baltar, J.; de Luis, D.
    Year: 2024
    Citation: Journal of Endocrinological Investigation, DOI: 10.1007/s40618-024-02364-9

  • Does the Ketogenic Diet Mediate Inflammation Markers in Obese and Overweight Adults? A Systematic Review and Meta-Analysis of Randomized Clinical Trials
    Authors: Rondanelli, M.; Gasparri, C.; Pirola, M.; Barrile, G.C.; Moroni, A.; Sajoux, I.; Perna, S.
    Year: 2024
    Citation: Nutrients, DOI: 10.3390/nu16234002

  • Efficacy of very low-calorie ketogenic diet with the Pronokal® method in obese women with polycystic ovary syndrome: a 16-week randomized controlled trial
    Authors: Pandurevic, S.; Mancini, I.; Mitselman, D.; Magagnoli, M.; Teglia, R.; Fazzeri, R.; Dionese, P.; Cecchetti, C.; Caprio, M.; Moretti, C.; Sajoux, I.
    Year: 2023
    Citation: Endocrine Connections, DOI: 10.1530/ec-22-0536

  • Very low calorie ketogenic diet and common rheumatic disorders: A case report
    Authors: Rondanelli, M.; Patelli, Z.; Gasparri, C.; Mansueto, F.; Ferraris, C.; Nichetti, M.; Alalwan, T.A.; Sajoux, I.; Maugeri, R.; Perna, S.
    Year: 2023
    Citation: World Journal of Clinical Cases, DOI: 10.12998/wjcc.v11.i9.1985

  • Immunomodulatory effect of a very-low-calorie ketogenic diet compared with bariatric surgery and a low-calorie diet in patients with excessive body weight
    Authors: Lorenzo, P.M.; Sajoux, I.; Izquierdo, A.G.; Gomez-Arbelaez, D.; Zulet, M.A.; Abete, I.; Castro, A.I.; Baltar, J.; Portillo, M.P.; Tinahones, F.J.
    Year: 2022
    Citation: Clinical Nutrition (Edinburgh, Scotland), DOI: 10.1016/j.clnu.2022.05.007

  • Severe type 2 diabetes (T2D) remission using a very low-calorie ketogenic diet (VLCKD)
    Authors: Correa, L.L.; de Sousa, P.A.M.; Dinis, L.; Carloto, L.B.; Nuñez-Garcia, M.; Sajoux, I.; Senhorini, S.
    Year: 2022
    Citation: Endocrinology, Diabetes & Metabolism Case Reports, DOI: 10.1530/edm-22-0295

  • Corrigendum: The Potential Roles of Very Low Calorie, Very Low Calorie Ketogenic Diets and Very Low Carbohydrate Diets on the Gut Microbiota Composition
    Authors: Rondanelli, M.; Gasparri, C.; Peroni, G.; Faliva, M.A.; Naso, M.; Perna, S.; Bazire, P.; Sajoux, I.; Maugeri, R.; Rigon, C.
    Year: 2021
    Citation: Frontiers in Endocrinology, DOI: 10.3389/fendo.2021.825790

  • Effectiveness and Safety of a Very Low-Calorie Ketogenic Diet on Weight Regain Following Bariatric Surgery
    Authors: Correa, L.L.; Moretti, A.; de Sousa, P.A.M.; Dinis, L.; de Souza, M.F.; Tostes, I.; Nuñez-Garcia, M.; Sajoux, I.
    Year: 2021
    Citation: Obesity Surgery, DOI: 10.1007/s11695-021-05703-4

  • Epigenetic landscape in blood leukocytes following ketosis and weight loss induced by a very low calorie ketogenic diet (VLCKD) in patients with obesity
    Authors: Crujeiras, A.B.; Izquierdo, A.G.; Primo, D.; Milagro, F.I.; Sajoux, I.; Jácome, A.; Fernandez-Quintela, A.; Portillo, M.P.; Martínez, J.A.; Martinez-Olmos, M.A.
    Year: 2021
    Citation: Clinical Nutrition (Edinburgh, Scotland), DOI: 10.1016/j.clnu.2021.05.010

  • Randomized Clinical Trial to Evaluate the Morphological Changes in the Adventitial Vasa Vasorum Density and Biological Markers of Endothelial Dysfunction in Subjects with Moderate Obesity Undergoing a Very Low-Calorie Ketogenic Diet
    Authors: Sánchez, E.; Santos, M.D.; Nuñez-Garcia, M.; Bueno, M.; Sajoux, I.; Yeramian, A.; Lecube, A.
    Year: 2021
    Citation: Nutrients, DOI: 10.3390/nu14010033

Nowreen Haq | Endocrinology and Metabolism | Best Researcher Award

Published on by Global Scholar Awards

Dr.Nowreen Haq | Endocrinology and Metabolism | Best Researcher Award

Asst Program Director at AAMC Medical Center Internal Medicine Residency program and division of endocrinology, metabolism,United States

Dr. Nowreen Haq, MD, MPH, is a highly accomplished physician-researcher with specialized expertise in endocrinology, metabolism, obesity, and preventive medicine. Her leadership as Principal Investigator at the NIH, particularly in machine learning-based clinical research, reflects a deep commitment to advancing evidence-based medicine. Dr. Haq has played key roles in academic institutions such as Johns Hopkins, NYU, and the University of Maryland, where she has influenced clinical education and residency program development. Her contributions to national committees and protocol development highlight her impact on healthcare policy and clinical standards. She has been recognized with multiple grants for quality improvement and patient safety initiatives, demonstrating her ability to translate research into meaningful outcomes. While greater visibility into her publication record could further bolster her profile, Dr. Haq’s multidisciplinary approach, clinical innovation, and dedication to improving patient care make her a strong and deserving candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Nowreen Haq has an extensive and distinguished educational background that spans international and U.S. institutions. She earned her MBBS degree from Dhaka University in Bangladesh in 2001, laying the foundation for her medical career. She then pursued a Master of Public Health (MPH) from the prestigious Johns Hopkins Bloomberg School of Public Health in 2006, where she gained advanced training in public health and preventive medicine. Dr. Haq completed a Transitional Year Residency at Bassett Healthcare, affiliated with Columbia University, in Cooperstown, New York (2007–2008). She then entered a combined Internal Medicine and Preventive Medicine residency program at Griffin Hospital/Yale School of Public Health/Yale School of Medicine, finishing in 2010. Her academic journey reflects a commitment to excellence, integrating clinical medicine with public health. Dr. Haq is board-certified in Internal Medicine, Endocrinology & Metabolism, and Obesity Medicine, demonstrating a multidisciplinary expertise that enhances both her clinical practice and research contributions.

Professional Experience📝

Dr. Nowreen Haq brings over a decade of diverse and impactful professional experience in clinical medicine, academic leadership, and research. She currently serves as a Physician Executive and Endocrinologist at Luminis Healthcare, where she also holds the role of Assistant Program Director for the Internal Medicine Residency Program. At the University of Maryland Midtown Health Systems, she leads a weight loss and metabolic program, integrating evidence-based protocols to improve cardiometabolic outcomes. Previously, she held clinical and leadership roles at institutions such as Chase Brexton Healthcare, Greater Baltimore Medical Center, NYU Langone, and Johns Hopkins Bayview Medical Center. Dr. Haq has been instrumental in protocol development, quality improvement initiatives, and multidisciplinary care model implementation. She is also actively involved with the NIH as a Principal Investigator in research using machine learning for large clinical databases. Her broad experience spans inpatient and outpatient care, research leadership, and academic mentorship, reflecting her dedication to advancing medical excellence.

Research Interest🔎

Dr. Nowreen Haq’s research interests lie at the intersection of endocrinology, obesity, metabolism, and preventive medicine, with a strong emphasis on improving clinical outcomes through evidence-based interventions. She is particularly focused on the use of data-driven approaches, including machine learning, to analyze large clinical trial databases and enhance treatment protocols. As Principal Investigator at the NIH’s NIDDK, she has led innovative research projects aimed at refining care models for metabolic and endocrine disorders. Dr. Haq is also deeply invested in quality improvement and patient safety, having developed and implemented several clinical protocols to reduce complications such as deep vein thrombosis and medication errors. Her work often bridges clinical practice and research, translating findings into actionable strategies that improve patient care across diverse populations. Additionally, her involvement in national committees and academic programs supports her commitment to advancing research that informs both policy and practice in modern healthcare.

Award and Honor🏆

Dr. Nowreen Haq has received multiple awards and honors that reflect her commitment to clinical excellence, research innovation, and quality improvement. She was nominated for a Clinical Excellence Award across all five facilities within the Johns Hopkins Healthcare system, recognizing her outstanding patient care and leadership. Dr. Haq is a two-time recipient of the prestigious Pyramid Small Grant for Patient Safety and Quality Improvement, awarded for her work on enhancing medication safety and preventing deep vein thrombosis in post-discharge patients. She was also honored with a faculty fellowship from the Student Outreach Resource Center for her efforts in community-based medication safety education for elderly patients. Additionally, she received a research grant from the Agency for Healthcare Quality and Research (AHRQ) to study the utilization of cardiac resynchronization therapy in Medicare patients. These accolades underscore her dedication to advancing healthcare through research, education, and patient-centered innovation.

Research Skill🔬

Dr. Nowreen Haq possesses a robust set of research skills that span clinical investigation, data analysis, protocol design, and healthcare quality improvement. As a Principal Investigator at the NIH’s National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), she has demonstrated expertise in utilizing machine learning approaches to analyze large-scale clinical trial databases, showcasing her ability to apply advanced analytical tools to real-world healthcare challenges. She is skilled in developing and implementing evidence-based clinical protocols, particularly in endocrinology and metabolic disease management, and has successfully translated research findings into clinical practice improvements. Dr. Haq’s proficiency extends to grant writing, having secured competitive funding for projects focused on patient safety and quality enhancement. Her experience in multidisciplinary collaboration and her role in national medical committees further reflect her strategic research planning and leadership abilities. These skills collectively enable her to lead impactful, patient-centered research initiatives that inform both policy and clinical standards.

Conclusion💡

Dr. Nowreen Haq is exceptionally qualified for the Best Researcher Award, particularly due to her blend of clinical excellence, leadership in protocol development, innovative research using machine learning, and strong academic roles. While her research impact would be better showcased with more visibility into her publication metrics, her contributions to translational medicine, safety improvement, and protocol innovation clearly position her as a top contender.

Publications Top Noted✍

  • Title: Metabolically healthy obesity, transition to metabolic syndrome, and cardiovascular risk
    Authors: M Mongraw-Chaffin, MC Foster, CAM Anderson, GL Burke, N Haq, …
    Year: 2018
    Citations: 436
    Journal: Journal of the American College of Cardiology, 71(17), 1857–1865

  • Title: Role of intensive glucose control in development of renal end points in type 2 diabetes mellitus: systematic review and meta-analysis
    Authors: SG Coca, F Ismail-Beigi, N Haq, HM Krumholz, CR Parikh
    Year: 2012
    Citations: 373
    Journal: Archives of Internal Medicine, 172(10), 761–769

  • Title: Predictors of response to cardiac resynchronization therapy: a systematic review
    Authors: J Rickard, H Michtalik, R Sharma, Z Berger, E Iyoha, AR Green, N Haq, …
    Year: 2016
    Citations: 98
    Journal: International Journal of Cardiology, 225, 345–352

  • Title: Acute changes in N-terminal pro-B-type natriuretic peptide during hospitalization and risk of readmission and mortality in patients with heart failure
    Authors: HJ Michtalik, HC Yeh, CY Campbell, N Haq, H Park, W Clarke, …
    Year: 2011
    Citations: 82
    Journal: The American Journal of Cardiology, 107(8), 1191–1195

  • Title: Atherosclerotic cardiovascular disease screening in adults: American College of Preventive Medicine position statement on preventive practice
    Authors: LS Lim, N Haq, S Mahmood, L Hoeksema, ACPM Committee
    Year: 2011
    Citations: 81
    Journal: American Journal of Preventive Medicine, 40(3), 381.e1–381.e10